Collaboration will empower clinicians to offer improved patient care through novel, high-quality genetic testing   Aliso Viejo, CA and Evanston, IL (September 12, 2017): Ambry Genetics (Ambry), a leading clinical genetics-testing lab, and NorthShore University HealthSystem’s (NorthShore) Center for Personalized Medicine announced today that they will be partnering to offer genetic testing and innovative research…

By analyzing both germline and somatic mutations, Ambry can clearly identify those with hereditary cancer as well as those who may benefit from PARP inhibitor treatment or PD-L1/PD-1 immunotherapy Aliso Viejo, CA: Ambry Genetics (Ambry), a leading clinical genetics-testing lab, is launching two game-changing paired (simultaneous germline and somatic) genetic tests, TumorNext-HRD and TumorNext-Lynch that…

DELRAY BEACH, FLA., April 26th, 2017—Progeny Genetics LLC (Progeny), a leading risk modeling pedigree software for clinicians, announced today that Jamie L’Heureux, MS, CGC has been appointed to the role of Chief Executive Officer. For 20 years, Progeny has assisted healthcare providers with patient screening, risk analysis, order processing, clinical review, and letter generation. Ms.…

ALISO VIEJO, CALIF., April 11th, 2017—Ambry Genetics Corporation (Ambry) is calling on psychiatrists, psychologists and behavioral specialists to encourage their patients with autism, along with their family members, to sign up for a new study conducted through Ambry’s data sharing program, AmbryShare. With this program, Ambry is taking a step towards discovering possible associations between…

ALISO VIEJO, CALIF., March 20th, 2017—Ambry Genetics (Ambry), whose mission is to put patients and genetics above all else, will present important new research at the 2017 ACMG Annual Clinical Genetics Meeting in Phoenix, Arizona. Ambry ‘s new scientific research may significantly impact clinical practices and guidelines in the form of 3 platform presentations and…

ALISO VIEJO, CALIF., February 21st, 2017—Ambry Genetics (Ambry) has created an online portal to enable more patients and families to participate in research through the AmbryShare program. With this simplified portal, Ambry has streamlined the research consent process to make cohort recruitment easier for clinicians at the time of sample collection for clinical testing. Patients…

ALISO VIEJO, CALIF., January 18, 2016—Ambry Genetics’ (Ambry)  data sharing program, AmbryShare, is one of the largest germline exome data sets on hereditary breast and ovarian cancer available to the public, with more than 1 million variants from 11,400 patients. This repository, originally announced in March of 2016 and previously only available to select researchers, is…

Aliso Viejo, CA – October 6, 2016 – Ambry Genetics (“Ambry”) today publishes data in The Journal of Molecular Diagnostics from the largest study to date1, 20,000 cases submitted for hereditary cancer panel testing, supporting its practice of Sanger sequencing next generation sequencing (NGS) variant calls. This step, integrated into Ambry’s workflow, allows for optimal results. Study findings show that…

Offers Solution to Recent Research Showing Higher Rate of Germline Mutations in Men with Metastatic Prostate Cancer Aliso Viejo, CA – September 28, 2016 – Ambry Genetics (Ambry) today announces that it has launched ProstateNext, a new 14-gene panel for hereditary prostate cancer. Ambry will feature it at the 2016 National Society of Genetic Counselors (NSGC) Annual Education…

ALISO VIEJO, CALIF., September 23, 2016—Ambry Genetics’ Chief Executive Officer, Aaron Elliott, Ph.D. received the Orange County Business Journal’s ‘Innovator of the Year’ award during a luncheon celebration with more than 300 people at the Hotel Irvine on Thursday, September 22nd, 2016. “If you look at Ambry Genetics today, we just opened a 65,000 square foot…